Corporate Sites
https://www.merck.com/index.html
Contact in CT:
Important News and Information
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) that is Not Curable by Surgery or Radiation 06/24/2020
c/o Dawn Holcombe
dawnho@aol.com
33 Woodmar Circle South Windsor, CT 06074 (860) 305-4510
Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds